IRIS
GIUSTI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.878
AS - Asia 28
Totale 14.906
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 14.878
CN - Cina 24
SG - Singapore 2
VN - Vietnam 2
Totale 14.906
Salva come PNG Salva come JPEG
Città #
Genova 9.117
Genoa 3.476
Rapallo 1.318
Vado Ligure 941
Bordighera 26
Beijing 11
Singapore 2
Da Nang 1
Ho Chi Minh City 1
Totale 14.893
Salva come PNG Salva come JPEG
Nome #
1,25-Dihydroxy vitamin D and coronary microvascular function 349
Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre. 203
Characteristics of a nationwide cohort of patients presenting with Isolated Hypogonadotropic Hypogonadism (IHH) 191
Detection of Polyethylene Glycol Thyrotropin (TSH) Precipitable Percentage (Macro-TSH) in Patients with a History of Thyroid Cancer 183
A case of thyroid cancer on the track of the radiofrequency electrode 30 months after percutaneous ablation 177
Cell specific interaction of pasireotide: review of preclinical studies in somatotroph and corticotroph pituitary cells 177
A study of the efficacy of radioiodine therapy with individualized dosimetry in Graves' disease: need to retarget the radiation committed dose to the thyroid. 176
Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system 174
Absence of histological malignancy in a patient cohort with follicular lesions on fine-needle aspiration 171
Calcitonin assay in wash-out fluid after fine-needle aspiration biopsy in patients with a thyroid nodule and border-line value of the hormone 168
Ten-year estimated risk of bone fracture in women with differentiated thyroid cancer under TSH-suppressive levothyroxine therapy 168
Evaluation of adequacy of levo-thyroxine dosage in patients with differentiated thyroid carcinoma: correlation between morning and afternoon TSH determination 168
Evaluation of Quality of Life in Patients with Differentiated Thyroid Cancer by Means of the Thyroid-Specific Patient-Reported Outcome Questionnaire: A 5-Year Longitudinal Study 166
A case-controlled study on the quality of life in a cohort of patients with history of differentiated thyroid carcinoma 164
An H-TERT Mutated Skin Metastasis as First Occurrence in a Case of Follicular Thyroid Carcinoma 164
Partial visual recovery from radiation-induced optic neuropathy after hyperbaric oxygen therapy in a patient with Cushing disease 162
The pathology of the ulnar nerve in acromegaly. 162
Case report: lenvatinib in neoadjuvant setting in a patient affected by invasive poorly differentiated thyroid carcinoma 162
Quality of Life in Patients Treated with Percutaneous Laser Ablation for Non-Functioning Benign Thyroid Nodules: A Prospective Single-Center Study 159
Increasing hirsutism due to a granulosa-cell tumor in a woman with polycystic ovary syndrome: case report and review of the literature. 156
Biochemical diagnosis and assessment of disease activity in acromegaly: a two-decade experience. 155
Circulating nitric oxide in women affected by weight loss amenorrhea during pulsatile gonadotropin-releasing hormone therapy 152
A unique association of clinical "persistent müllerian duct syndrome" and syringoid carcinoma of the perineal-scrotal skin: a consequence of urologic surgery? 152
Nitric oxide modulates in vivo and in vitro growth hormone release in acromegaly. 149
Low-Salt Intake Suggestions in Hypertensive Patients Do not Jeopardize Urinary Iodine Excretion 149
Anti-Müllerian hormone in pre-menopausal females after ablative radioiodine treatment for differentiated thyroid cancer 149
Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system 148
A comparison of laser with radiofrequency ablation for the treatment of benign thyroid nodules: a propensity score matching analysis 148
Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogs and dopastatins 147
Androgen replacement therapy in male patients with rheumatoid arthritis. 144
Clinical efficacy of radioiodine therapy in multinodular toxic goiter, applying an implemented dose calculation algorithm. 144
A. novel mechanism for the melatonin inhibition of testosterone secretion by rat Leydig cells: reduction of GnRH-induced cytosolic Ca2+ rise 143
Primary hyperparathyroidism in pregnancy treated with cinacalcet: A case report and review of the literature 143
Absence of thyrotropin-induced increase in leptin levels in patients with history of differentiated thyroid carcinoma undergoing recombinant human thyrotropin testing 142
Pituitary tumor disappearance in a patient with newly diagnosed acromegaly primarily treated with octreotide LAR 142
Therapeutic Strategies and Clinical Outcome in Papillary Thyroid Microcarcinoma: A Multicenter Observational Study. 142
A case of thyroiditis during natalizumab therapy for multiple sclerosis 142
Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation. 141
Retrospective cytological evaluation of indeterminate thyroid nodules according to the British Thyroid Association 2014 classification and comparison of clinical evaluation and outcomes 141
Relationship between circulating anti-thyroglobulin antibodies (TgAb) and tumor metabolism in patients with differentiated thyroid cancer (DTC): prognostic implications 140
The hypothalamic-pituitary-adrenocortical and gonadal axis function in rheumatoid arthritis. 139
Growth-hormone, prolactin and cortisol nyctohemeral variations during naloxone-induced opiate receptor blockade in man. 137
Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging. 137
Morphine-induced TSH release in normal and hypothyroid subjects. 135
Leptin, ghrelin, and adiponectin evaluation in transsexual subjects during hormonal treatments 135
Simple dietary advice reduces 24-hour urinary sodium excretion, blood pressure, and drug consumption in hypertensive patients 135
Role of Strain Elastography and Shear-Wave Elastography in a Multiparametric Clinical Approach to Indeterminate Cytology Thyroid Nodules 135
Ultrasonography thyroid volume estimation in hyperthyroid patients treated with individual radioiodine dose. 134
Parathyroid autotransplantation. 134
Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6. 134
Impact of pre-treatment with somatostatin analogs on surgical management of acromegalic patients referred to a single center 133
Treatment of a pituitary metastasis from a neuroendocrine tumour: case report and literature review. 133
Effect of different therapeutic modalities on spontaneous GH secretion in acromegalic patients 133
Androgen status in postmenopausal patients with rheumatoid arthritis. 131
Severe vitamin D deficiency is associated with frequently observed diseases in medical inpatients 131
Sympathovagal imbalance in acromegalic patients 130
Benign thyroid nodule unresponsive to radiofrequency ablation treated with laser ablation: a case report 129
Long-term outcome of low-activity radioiodine administration preceded by adjuvant recombinant human TSH pretreatment in elderly subjects with multinodular goiter. 128
Efficacy of sorafenib and impact on cardiac function in patients with thyroid cancer: a retrospective analysis. 126
Increased prevalence of Helicobacter pylori infection in females treated with dopaminergic drugs for hyperprolactinaemia. 125
Epidemiology of acromegaly in Italy: analysis from a large longitudinal primary care database 125
Papillary thyroid cancer in a struma ovarii: a report of a rare case 125
Slow-release lanreotide and octreotide LAR in the medical therapy of acromegaly. 124
Circulating nitric oxide changes throughout the menstrual cycle in healthy women and women affected by pathological hyperprolactinemia on dopamine agonist therapy. 122
Metabolic and cardiovascular risk in patients with a history of differentiated thyroid carcinoma: A case-controlled cohort study 122
Current diagnostic guidelines for biochemical diagnosis of acromegaly. 122
In memory of Francesco Maria Minuto. 121
Prolactin decrease and shift to a normal-like isoform profile during treatment with quinagolide in a patient affected by an invasive prolactinoma. 120
Institutional experience of PTH evaluation on fine-needle washing after aspiration biopsy to locate hyperfunctioning parathyroid tissue. 120
Replacement therapy and cardiovascular diseases 120
Effect of short-term treatment with low dosages of the proton-pump inhibitor omeprazole on serum chromogranin A levels in man. 118
Cost-of-illness study in acromegalic patients in Italy 116
Can baseline endocrinological examination and thyroid ultrasound predict the development of thyroid disease in immunotherapy-treated patients? Results from a prospective, single-center, open-label study 115
Altered stress response of adrenal steroids in premenopausal rheumatoid arthritis patients 115
Lanreotide 60 mg, a new long-acting formulation: effectiveness in the chronic treatment of acromegaly. 114
A very low vitamin D threshold, within the range of severe deficiency, identifies an increased risk of non-classical vitamin D-related outcomes in medical inpatients: a role for parathyroid hormone? 114
Cabergoline modulation of alpha-subunits and FSH secretion in a gonadotroph adenoma 114
Effects of melatonin on interleukin – 12 and nitric oxide production by cultured synovial macrophages in rheumatoid arthritis 113
Bilateral carcinoma in situ of the testis and cystic fibrosis transmembrane conductance regulator (CFTR) mutation in an azoospermic patient with late-onset 21beta-hydroxylase deficiency. 113
Testosterone metabolism and cyclosporin A treatment in rheumatoid arthritis. 113
Effects of recombinant human thyrotropin on heart rate variability and blood pressure in patients on l-thyroxine-suppressive therapy for differentiated thyroid carcinoma 112
Ranitidine and testosterone secretion in man. 110
Is there a real diagnostic impact of elastosonography and contrast-enhanced ultrasonography in the management of thyroid nodules? 110
Potential indications for somatostatin analogues: immune system and lymphoproliferative disorders 110
Desmopressin, ovine CRH, and low-dose ACTH tests: tools for the study of the hypothalamic-pituitary-adrenal axis in premenopausal rheumatoid arthritis patients. 106
Desmopressin and low-dose ACTH test in rheumatoid arthritis. 105
Five-year longitudinal evaluation of quality of life in a chort of patients with different thyroid carcinoma 105
Desmopressin, ovineCRH and low-dose ACTH tests: tools for the study of hypotalamus- pituitary-adrenal axis in premenopausal rheumatoid arthritis patients 100
Three-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diagnosis of acromegaly. 99
Preliminary results of serum androgen level testing in men with rheumatoid arthritis. 99
Syndrome of inappropriate antidiuretic hormone secretion and Ibuprofen, a rare association to be considered: role of tolvaptan. 97
In vitro effect of human recombinant leptin and expression of leptin receptors on growth hormone-secreting human pituitary adenomas 96
CYP17 polymorphisms and androgen levels in postmenopausal patients with rheumatoid arthritis. 95
Papillary carcinoma in struma ovarii: A case report 93
Prulifloxacin vs Levofloxacin for Exacerbation of COPD after Failure of Other Antibiotics 91
Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus. 90
PTH radioimmunoassay and loading tests in the diagnosis of patients with primary hyperparathyroidism. 87
The hypothalamic-pituitary-adrenal and gonadal axes in rheumatoid arthritis. 85
Somatostatin and its analog lanreotide inhibit the proliferation of dispersed human non-functioning pituitary adenoma cells in vitro 83
Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: six-month report on an Italian multicenter study. Italian Multicenter Slow Release Lanreotide Study Group. 83
Totale 13.489
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.233
article - articoli 44.219
book - libri 0
conference - conferenze 1.014
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.466
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021765 0 0 0 63 67 100 74 113 92 100 73 83
2021/20221.440 53 77 112 182 72 108 81 295 104 141 61 154
2022/20231.553 142 113 24 156 332 248 11 106 233 6 166 16
2023/2024816 41 94 6 107 74 146 54 36 42 37 66 113
2024/20252.468 84 163 115 156 305 223 278 420 81 90 265 288
2025/2026966 487 83 189 207 0 0 0 0 0 0 0 0
Totale 15.064